• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

Kentucky $1.74 Million Settlement Illustrates the Danger of Billing Medicare for Nonmedical Urine Drug Tests

Kentucky $1.74 Million Settlement Illustrates the Danger of Billing Medicare for Nonmedical Urine Drug Tests

by Glenn S. Demby | May 31, 2023 | Enforcement-lca, Lab Compliance Advisor

A recent False Claims Act settlement from Kentucky represents an unusual variation on a common theme.

This content is for Paid Members only.
Login Register
Convicted Lab Owner Fails to Report to Prison

Convicted Lab Owner Fails to Report to Prison

by Rachel Muenz | May 10, 2023 | News

In addition to the usual FCA-related fare, an arrest warrant was issued for a convicted lab co-owner after he failed to show up for prison.

Urine Drug & Genetic Testing Remain Top Enforcement Targets

Urine Drug & Genetic Testing Remain Top Enforcement Targets

by Rachel Muenz | May 3, 2023 | Enforcement-lca, Lab Compliance Advisor

In an analysis of enforcement actions from the end of 2022 to early spring 2023, cases involving urine drug testing were the most prevalent.

This content is for Paid Members only.
Login Register
Lab Owner Charged in Latest COVID-19 Fraud Crackdown

Lab Owner Charged in Latest COVID-19 Fraud Crackdown

by Rachel Muenz | Apr 26, 2023 | News

In the latest major COVID-19-related enforcement action, 18 individuals were charged in various schemes worth more than $490 million.

Medicaid Fraud Recoveries Drop Significantly in 2022

Medicaid Fraud Recoveries Drop Significantly in 2022

by Glenn S. Demby | Apr 19, 2023 | Enforcement-nir, National Lab Reporter

At $1.1 billion, total recoveries in 2022 did exceed $1 billion for the fourth year in a row, but dropped from $1.7 billion in FY 2021

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com